New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 12, 2014
10:28 EDTIDTI, AMJ, CBSO, SU, LULU, GERN, AR, ROSE, IYT, RHHigh option volume stocks:
High option volume stocks: IYT AR RH ROSE AMJ GERN SU IDTI LULU CBSO
News For IYT;AR;RH;ROSE;AMJ;GERN;SU;IDTI;LULU;CBSO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
November 14, 2014
07:12 EDTGERNGeron upgraded to Overweight from Neutral at Piper Jaffray
Subscribe for More Information
06:30 EDTLULUlululemon downgraded to Underperform from Neutral at Sterne Agee
Subscribe for More Information
November 13, 2014
18:40 EDTGERNOn The Fly: After Hours Movers
UP AFTER EARNINGS: TubeMogul (TUBE), up 12.4%... Weibo (WB), up 3.2%... Nordstrom (JWN), up 3.1%. ALSO HIGHER: Geron (GERN), up 30.7% after announcing a global strategic collaboration with Janssen Biotech... Baker Hughes (BHI), up 16.2% following reports that the company is in talks to be acquired by Halliburton (HAL)... Halliburton is up 1.4%... Pandora (P), up 4% after announcing a conference call to discuss Web IV proceeding... AmerisourceBergen (ABC), up 1.1% after being awarded a $4.06B government contract. DOWN AFTER EARNINGS: Retrophin (RTRX), down 6.6%... Phoenix New Media (FENG), down 8.4%... Voxeljet AG (VJET), down 8.6%... Intrexon (XON), down 1.1%... Youku Tudou (YOKU), down 5.7%... Applied Materials (AMAT), down 2.5%. ALSO LOWER: Puma Biotechnology (PBYI), down 6.9% following PB272 Phase II Trial results... EnLink Midstream (ENLK), down 4.8% after filing to sell 10.5M common units representing limited partners.
16:28 EDTGERNGeron announces global strategic collaboration with Janssen Biotech
Geron (GERN) announced that the company has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, a Johnson & Johnson (JNJ) company, to develop and commercialize, imetelstat, Geron's telomerase inhibitor product candidate, for oncology, including hematologic malignancies, and other human therapeutics uses. Imetelstat is a modified oligonucleotide that is currently in early phase clinical development for myelofibrosis, or MF, and may have activity in other hematologic myeloid malignancies such as myelodysplastic syndrome, or MDS, and acute myelogenous leukemia, or AML. Under the terms of the agreement, Geron will receive an initial payment of $35M due after the applicable waiting periods under the Hart-Scott Rodino Act and is eligible to receive additional payments up to a potential total of $900M for the achievement of development, regulatory and commercial milestones, as well as royalties on worldwide net sales. Certain regulatory, development, manufacturing and promotional activities will be managed through a joint governance structure, with Janssen responsible for operational implementation of these activities. All sales will be booked by Janssen.
13:32 EDTGERNLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:29 EDTGERNLeerink biotech analysts hold an analyst/industry conference call
Subscribe for More Information
13:26 EDTGERNLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including Leukemia/MDS on an Analyst/Industry conference call to be held on November 20 at 10 am.
10:01 EDTROSEOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:45 EDTIYTISHARES DJ TRANS AVG: Pivot points
Subscribe for More Information
08:29 EDTROSERosetta Resources upgraded at BMO Capital
Subscribe for More Information
06:04 EDTLULUStocks with implied volatility above IV index mean; GME LULU
Subscribe for More Information
04:10 EDTROSERosetta Resources upgraded to Outperform from Market Perform at BMO Capital
November 12, 2014
13:31 EDTLULULululemon Athletica volatility elevated as shares trend higher
Subscribe for More Information
08:45 EDTIYTISHARES DJ TRANS AVG: Pivot points
The following are the pivot points for IYT. Pivot High: $162.690, Pivot Low: $161.320. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.
November 11, 2014
16:14 EDTGERNLeerink biotech analysts hold an analyst/industry conference call
Biotech Analysts provide a preview of items being discussed at the upcoming 56th Annual Meeting of ASH including JAK inhibitors, novel Jakafi combinations for Myelofibrosis and developing compounds on an Analyst/Industry conference call to be held on November 17 at 10 am.
08:45 EDTIYTISHARES DJ TRANS AVG: Pivot points
Subscribe for More Information
November 10, 2014
09:46 EDTLULUBB&T remains positive on lululemon following channel checks
BB&T said it remains positive on lululemon following recent channel checks. The firm continues to expect lululemon's results to improve as the company improved product assortment and laps 2013 PR stumbles. BB&T views the hire of Duke Stump as EVP of Community and Brand as a a positive and views the controversy over the donation to the Dalai Lama Center as overblown. Shares are Buy rated with a $50 price target.
08:45 EDTIYTISHARES DJ TRANS AVG: Pivot points
The following are the pivot points for IYT. Pivot High: $160.630, Pivot Low: $159.270. These were calculated using the DeMark method. It is generally believed to be bullish when price breaks out above the pivot high or bearish when price breaks down below the pivot low.
07:22 EDTLULUU.S. Retail Softlines sector downgraded to Negative at Barclays
Subscribe for More Information
05:48 EDTLULUU.S. Retail Softlines industry cut to Negative at Barclays
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use